Both in Pharmaceuticals
Biohaven vs Aurinia Pharmaceuticals
Over the past year BHVN returned +5.1% and AUPH returned +25.7%; their daily moves had a correlation of 0.20.
BHVN +5.1% AUPH +25.7%Growth of $1, one year, split-adjusted
| Metric | BHVN | AUPH |
|---|---|---|
| Price | $15.61 | $16.56 |
| Market cap | $2.36B | $2.22B |
| Today | +2.97% | +2.60% |
| 1 month | +20.4% | +5.3% |
| 6 months | +60.8% | +3.2% |
| Year to date | +38.3% | +3.8% |
| 1 year | −9.2% | +25.7% |
| Revenue growth (YoY) | — | +13.9% |
| Gross margin | — | 90.1% |
| Net margin | — | 37.9% |
| P/E (TTM) | — | 7.1× |
| Price / sales | — | 6.9× |
| Net cash | -$103.2M | $431.7M |
| Dividend yield | — | — |
| Volatility (60d) | 91.0% | 30.3% |
| Short % of float | 14.9% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).